Medicamen Biotech has attached disclosure dated March 16, 2024 in Form-D pursuant to Regulation 7(3) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 with respect to intimation received from Geetika Madan, immediate relative of Rajesh Madan, Chief Executive Officer for sale of 28100 Equity Shares from the open market.
The above information is a part of company’s filings submitted to BSE.